The hypoxia metabolism gene PYGL was discovered to be upregulated in many malignancies, including breast cancers and head and neck squamous cell carcinomas (Kawakubo-Yasukochi et al., 2021; Zhao et al., 2021). This evidence concerns the gene PYGL and breast cancer.